Comparative Pharmacology
Head-to-head clinical analysis: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE versus INDERIDE 40 25.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE versus INDERIDE 40 25.
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE vs INDERIDE-40/25
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Bisoprolol is a cardioselective beta-1 adrenergic receptor antagonist that reduces heart rate and myocardial contractility, decreasing cardiac output. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium-chloride symporter in distal convoluted tubule, reducing plasma volume.
Inderide-40/25 is a combination of propranolol (non-cardioselective beta-blocker) and hydrochlorothiazide (thiazide diuretic). Propranolol reduces heart rate, myocardial contractility, and renin secretion via beta-adrenergic receptor blockade. Hydrochlorothiazide inhibits Na+/Cl- cotransporter in distal convoluted tubule, increasing excretion of Na+, Cl-, and water; also reduces peripheral vascular resistance.
One tablet orally once daily. Initial dose: 2.5 mg/6.25 mg to 10 mg/25 mg, titrated based on response. Maximum: 20 mg/50 mg per day.
One tablet (40 mg propranolol HCl/25 mg hydrochlorothiazide) orally twice daily; may increase to maximum of 160 mg propranolol/100 mg hydrochlorothiazide per day in divided doses.
None Documented
None Documented
Bisoprolol: terminal half-life 10-12 hours (up to 15 hours in elderly/clinically significant for once-daily dosing); Hydrochlorothiazide: terminal half-life 6-15 hours (prolonged in renal impairment).
Propranolol: 3-6 hours (terminal); clinical context: dosing 2-3 times daily due to short half-life; may accumulate in hepatic impairment. Hydrochlorothiazide: 6-15 hours (terminal); clinical context: longer in renal impairment.
Bisoprolol: 50% unchanged in urine, remainder as inactive metabolites; Hydrochlorothiazide: 95% unchanged in urine. Fecal elimination: negligible.
Propranolol: extensively metabolized in liver via CYP2D6 and glucuronidation; <1% excreted unchanged in urine. Hydrochlorothiazide: ~70% excreted unchanged in urine via tubular secretion.
Category A/B
Category C
Thiazide Diuretic
Beta Blocker and Thiazide Diuretic